Drawing for KIMOZO

USPTO serial 79340837

KIMOZO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
TURNER, JASON FITZGERALD
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with KIMOZO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Autonomic drugs for medical use; medicines; medicines for human medicine; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations; pharmaceutical preparations for treatment of diseases affecting the peripheral nervous system; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical products for prevention of nervous system diseases; pharmaceutical products for prevention of nervous system disorders; chemotherapeutic agents; anti-cancer drugs; compounds for pharmaceutical use; cancer treatment compounds; pharmaceutical preparations and substances for cancer treatment; preparations and substances for medical use for removing tumors; Pharmaceutical substances and preparations used in oncology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 12, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 12, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 25, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 11, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 11, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 11, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 31, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 30, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2022DOCKASSIGNED TO EXAMINER—
May 24, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance